tiprankstipranks
Verastem appoints Matthew Ros as COO
PremiumThe FlyVerastem appoints Matthew Ros as COO
2M ago
Verastem exercises early option to license VS-7375 from GenFleet Therapeutics
Premium
The Fly
Verastem exercises early option to license VS-7375 from GenFleet Therapeutics
2M ago
Verastem Strengthens Financials and Partnerships for Drug Launch
Premium
Company Announcements
Verastem Strengthens Financials and Partnerships for Drug Launch
2M ago
Verastem price target raised to $20 from $13 at BTIG
PremiumThe FlyVerastem price target raised to $20 from $13 at BTIG
3M ago
3 Best Stocks to Buy Now, 12/31/2024, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 12/31/2024, According to Top Analysts
3M ago
Verastem announces FDA acceptance and Priority Review of NDA for Avutometinib
Premium
The Fly
Verastem announces FDA acceptance and Priority Review of NDA for Avutometinib
3M ago
Verastem price target lowered to $14 from $20 at Alliance Global Partners
PremiumThe FlyVerastem price target lowered to $14 from $20 at Alliance Global Partners
4M ago
Verastem cuts FY24 EPS view to $4.17-$4.23 from $4.25-$4.35, consensus $4.28
Premium
The Fly
Verastem cuts FY24 EPS view to $4.17-$4.23 from $4.25-$4.35, consensus $4.28
4M ago
Verastem reports Q3 EPS (60c), consensus (74c)
Premium
The Fly
Verastem reports Q3 EPS (60c), consensus (74c)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100